ctrl K

Watchlist Price Alert

Freeline Therapeutics (FRLN)

NASDAQ: FRLN · Real-Time Price · USD

6.49

0.01 (0.15%)

At close: Feb 16, 2024, 8:37 PM

Freeline Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.74M	2.39M	1.93M	1.55M	n/a
Gross Profit	-1.74M	-2.39M	-1.93M	-1.55M	n/a
Operating Income	-98.45M	-142.38M	-102.45M	-63.64M	-40.98M
Interest Income	904K	403.95K	275K	74.31K	n/a
Pretax Income	-88.6M	-140.05M	-96.19M	-53.77M	-33.26M
Net Income	-88.97M	-140.39M	-96.32M	-53.91M	-33.28M
Selling & General & Admin	30.66M	44.57M	26.3M	16.6M	6.79M
Research & Development	66.2M	95.43M	76.15M	47.04M	34.19M
Other Expenses	-1.57M	-2.09M	-15.27M	-10.6M	-390K
Operating Expenses	95.29M	137.91M	87.18M	53.05M	32.72M
Interest Expense	n/a	n/a	n/a	n/a	151K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	95.29M	137.91M	87.18M	53.05M	32.72M
Income Tax Expense	368K	342K	129K	141K	27K
Shares Outstanding (Basic)	3.95M	2.38M	943.52K	423.19K	423.19K
Shares Outstanding (Diluted)	3.95M	2.38M	943.52K	423.19K	423.19K
EPS (Basic)	-22.52	-58.98	-102.09	-127.39	-78.65
EPS (Diluted)	-22.52	-58.98	-102.09	-127.39	-78.65
EBITDA	-97.17M	-133.14M	-85.27M	-51.51M	-32.13M
EBIT	-98.92M	n/a	n/a	n/a	-41.22M
Depreciation & Amortization	1.27M	9.24M	17.18M	12.13M	970K